Home/ACT Genomics/Shu Jen Chen

SJ

Shu Jen Chen

Chief Advisor

Therapeutic Areas

ACT Genomics Pipeline

Drug	Indication	Phase
ACTOnco® IVD	Solid Tumors	Commercial
ACTMonitor	Solid Tumors (Longitudinal Monitoring)	Commercial

Leadership Team at ACT Genomics

Chief Executive Officer & Co‑Founder

Chief Financial Officer

View full ACT Genomics profile